FGFR2 and neoplasm: We sequenced the protein-coding exons 5 and 7–9 in about 50 patients and exons 12–15 in about 140 patients as well as adjacent intronic sequences and we identified one novel heterozygous missense mutation in exon 14 of FGFR2, c.1980G>C, in tumor tissue of one of them (BC80).